Aurora Cannabis (TSE:ACB) Reaches New 52-Week High at $12.83

Aurora Cannabis Inc. (TSE:ACB) hit a new 52-week high during trading on Tuesday . The company traded as high as C$12.83 and last traded at C$12.65, with a volume of 7322643 shares trading hands. The stock had previously closed at C$8.65.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on ACB shares. Jefferies Financial Group lowered their price target on Aurora Cannabis from C$6.12 to C$4.95 and set a “hold” rating for the company in a research note on Tuesday, February 27th. Canaccord Genuity Group upgraded shares of Aurora Cannabis from a “hold” rating to a “buy” rating and set a C$0.80 price objective for the company in a research note on Friday, February 9th. Finally, CIBC lowered their target price on shares of Aurora Cannabis to C$6.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 21st.

Aurora Cannabis Stock Performance

The stock has a fifty day moving average price of C$6.44 and a 200-day moving average price of C$2.67. The company has a current ratio of 3.79, a quick ratio of 2.48 and a debt-to-equity ratio of 18.51. The firm has a market capitalization of C$689.93 million, a price-to-earnings ratio of -0.16 and a beta of 2.83.

Aurora Cannabis (TSE:ACB) last released its quarterly earnings data on Thursday, February 8th. The company reported C($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of C($0.10) by C($0.10). Aurora Cannabis had a negative return on equity of 137.28% and a net margin of 151.71%. The company had revenue of C$72.61 million for the quarter, compared to analyst estimates of C$63.50 million. As a group, analysts anticipate that Aurora Cannabis Inc. will post -0.22 earnings per share for the current fiscal year.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.